Nrf2: a dark horse in doxorubicin-induced cardiotoxicity

Being a broad-spectrum anticancer drug, doxorubicin is indispensable for clinical treatment. Unexpectedly, its cardiotoxic side effects have proven to be a formidable obstacle. Numerous studies are currently devoted to elucidating the pathological mechanisms underlying doxorubicin-induced cardiotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaopeng, Tian, Zheng, Sun, Mingli, Dong, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372151/
https://www.ncbi.nlm.nih.gov/pubmed/37495572
http://dx.doi.org/10.1038/s41420-023-01565-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372151/
https://www.ncbi.nlm.nih.gov/pubmed/37495572
http://dx.doi.org/10.1038/s41420-023-01565-0

Ejemplares similares